ATLASZevra Therapeutics (ZVRA) earnings date: Nov 3, 2026
Zevra Therapeutics (ZVRA) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026, after the close. Analysts expect EPS of $0.14.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ZVRA
| Last price | $10.08 (-2.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.1% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Zevra Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Zevra Therapeutics reports on Nov 3, 2026. One email the day before, with ATLAS’s read on Zevra Therapeutics. You can switch it off at any time.
Alert me before ZVRA reportsFree to start. Creating an account takes under a minute.
Notify me when Zevra Therapeutics reports
Track ZVRA free Add Zevra Therapeutics to a free ATLAS watchlist and see its next report date in one place.
ZVRA earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $0.14 |
| Last report | Aug 5, 2026 · Beat |
| Beat rate (last 4 reports) | 4 of 4 (100%) |
| Average EPS surprise | +112.5% |
| Average move around a report | ±10.8% (last 4) |
| Sector | Healthcare · Biotechnology |
Zevra Therapeutics earnings history: last 4 reports
Zevra Therapeutics last reported on Aug 5, 2026: EPS of $0.25 against an estimate of $0.18 (+38.9% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 5, 2026 | $0.18 | $0.25 | +38.9% | Beat | +12.9% |
| May 6, 2026 | $0.08 | $0.18 | +125.0% | Beat | +3.7% |
| Mar 19, 2026 | $0.16 | $0.17 | +6.3% | Beat | -3.4% |
| Mar 9, 2026 | $0.05 | $0.19 | +280.0% | Beat | +23.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ZVRA
See the fair value, the probability range and the earnings history of Zevra Therapeutics on its ATLAS page.
Zevra Therapeutics (ZVRA) stock analysisPlans from €3.99 a month.
Zevra Therapeutics earnings: frequently asked questions
When does Zevra Therapeutics (ZVRA) report earnings?
Zevra Therapeutics is scheduled to report on Tuesday, November 3, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ZVRA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $0.14 per share (USD). Estimates can change before the report.
How often does ZVRA beat earnings estimates?
Of its last 4 reports with a recorded result, Zevra Therapeutics beat the EPS estimate 4 times; the average surprise was +112.5%. Past results do not predict the next one.
How much does ZVRA move around earnings?
Over its last 4 reports the stock moved an average of 10.8% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did Zevra Therapeutics beat earnings estimates last quarter?
Zevra Therapeutics last reported on Aug 5, 2026: EPS of $0.25 against an estimate of $0.18 (+38.9% surprise), a beat.
How much does ZVRA usually move in a day?
On a normal trading day the ATLAS model puts ZVRA’s one-day range at about ±3.1%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer